The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Open accessAbstract
Background: There is a growing interest in the use of cannabis (and its extracts), as well as CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is reason to believe that cannabinoids may be efficacious for a number of different diseases and syndromes, there exist limited objective data supporting the use of crude materials (CBD oil, cannabis extracts, and/or cannabis itself). Summary: In the present review, we examined data for pure cannabinoid compounds (dronabinol, nabilone, and CBD), as well as partially purified medicinal cannabis extracts (nabiximols), to provide guidance on the potential therapeutic uses of high-THC cannabis and CBD oil. In general, data support a role for cannabis/cannabinoids in pain, seizure disorders, appetite stimulation, muscle spasticity, and treatment of nausea/vomiting. Given the biological activities of the cannabinoids, there may be utility in treatment of central nervous system disorders (such as neurodegenerative diseases, PTSD, and addiction) or for the treatment of cancer. However, those data are much less compelling. Key Message: On balance, there are reasons to support the potential use of medical cannabis and cannabis extract (Δ 9-THC-dominant or CBD-dominant), but much more careful research is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
The Pathophysiology and Treatment of Glaucoma: A Review
Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014) · JAMA · doi:10.1001/jama.2014.3192 · Cited by 4,210
Vincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,586
Glioblastoma and Other Malignant Gliomas: A Clinical Review
Omuro, A. (2013) · JAMA · doi:10.1001/jama.2013.280319 · Cited by 2,301
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Cannabis sativa: The Plant of the Thousand and One Molecules
Andre, C. M., Hausman, J.-F., & Guerriero, G. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.00019 · Cited by 1,544
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Cancer cachexia: understanding the molecular basis
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3829 · Cited by 1,517
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Zou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,343
The Clinical Opiate Withdrawal Scale (COWS)
Wesson, D. R., & Ling, W. (2003) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2003.10400007 · Cited by 1,120
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,120
Human Cannabinoid Pharmacokinetics
Huestis, M. A. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790152 · Cited by 1,102
Cannabinoids and the expanded endocannabinoid system in neurological disorders
Cristino, L., Bisogno, T., & Di Marzo, V. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0284-z · Cited by 970
Seizures and Epilepsy: An Overview for Neuroscientists
Stafstrom, C. E., & Carmant, L. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022426 · Cited by 933
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Marconi, A., Di Forti, M., Lewis, C. M., Murray, R. M., & Vassos, E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw003 · Cited by 899
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871
The weight of nations: an estimation of adult human biomass
Walpole, S. C., Prieto-Merino, D., Edwards, P., Cleland, J., Stevens, G., & Roberts, I. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-439 · Cited by 862
Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 756
Breast cancer as a systemic disease: a view of metastasis
Redig, A. J., & McAllister, S. S. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12084 · Cited by 709
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Belbasis, L., Bellou, V., Evangelou, E., Ioannidis, J. P. A., & Tzoulaki, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70267-4 · Cited by 671
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Pharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Labeling Accuracy of Cannabidiol Extracts Sold Online
Bonn-Miller, M. O., Loflin, M. J. E., Thomas, B. F., Marcu, J. P., Hyke, T., & Vandrey, R. (2017) · JAMA · doi:10.1001/jama.2017.11909 · Cited by 529
New trends in cannabis potency in USA and Europe during the last decade (2008–2017)
Chandra, S., Radwan, M. M., Majumdar, C. G., Church, J. C., Freeman, T. P., & ElSohly, M. A. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00983-5 · Cited by 469
The Endocannabinoid System and its Modulation by Phytocannabinoids
Di Marzo, V., & Piscitelli, F. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0374-6 · Cited by 432
Boehnke, K. F., Litinas, E., & Clauw, D. J. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2016.03.002 · Cited by 412
Secondary metabolism in cannabis
Flores-Sanchez, I. J., & Verpoorte, R. (2008) · Phytochemistry Reviews · doi:10.1007/s11101-008-9094-4 · Cited by 400
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Colorectal Cancer Stem Cells: From the Crypt to the Clinic
Zeuner, A., Todaro, M., Stassi, G., & De Maria, R. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.11.012 · Cited by 368
Karussis, D. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.01.022 · Cited by 366
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study
Sieradzan, K. A., Fox, S. H., Hill, M., Dick, J. P. R., Crossman, A. R., & Brotchie, J. M. (2001) · Neurology · doi:10.1212/wnl.57.11.2108 · Cited by 349
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76f70 · Cited by 324
Jetly, R., Heber, A., Fraser, G., & Boisvert, D. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.002 · Cited by 321
Cannabinoid–Opioid Interaction in Chronic Pain
Abrams, D. I., Couey, P., Shade, S. B., Kelly, M. E., & Benowitz, N. L. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.188 · Cited by 319
Kuepper, R., van Os, J., Lieb, R., Wittchen, H.-U., Hofler, M., & Henquet, C. (2011) · BMJ · doi:10.1136/bmj.d738 · Cited by 304
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303
Endocannabinoids and Their Pharmacological Actions
Pertwee, R. G. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-20825-1_1 · Cited by 300
A Cross-Sectional Study of Cannabidiol Users
Corroon, J., & Phillips, J. A. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0006 · Cited by 289
Pharmacology of Medical Cannabis
Amin, M. R., & Ali, D. W. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-21737-2_8 · Cited by 278
Rosenberg, E. C., Tsien, R. W., Whalley, B. J., & Devinsky, O. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0375-5 · Cited by 276
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Bruni, N., Della Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018) · Molecules · doi:10.3390/molecules23102478 · Cited by 272
Post-traumatic stress disorder
Bisson, J. I., Cosgrove, S., Lewis, C., & Roberts, N. P. (2015) · BMJ · doi:10.1136/bmj.h6161 · Cited by 271
McPartland, J. M., Glass, M., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707399 · Cited by 266
Peripheral Neuropathy: A Practical Approach to Diagnosis and Symptom Management
Watson, J. C., & Dyck, P. J. B. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.004 · Cited by 258
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Blázquez, C., González-Feria, L., Álvarez, L., Haro, A., Casanova, M. L., & Guzmán, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3927 · Cited by 255
Parsing the players: 2‐arachidonoylglycerol synthesis and degradation in the CNS
Murataeva, N., Straiker, A., & Mackie, K. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12411 · Cited by 251
Baron, E. P. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 251
Cascio, M., Gauson, L., Stevenson, L., Ross, R., & Pertwee, R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00515.x · Cited by 241
Kosiba, J. D., Maisto, S. A., & Ditre, J. W. (2019) · Social Science & Medicine · doi:10.1016/j.socscimed.2019.06.005 · Cited by 237
Fellermeier, M., & Zenk, M. H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00450-5 · Cited by 230
The endocannabinoid system: emotion, learning and addiction
Moreira, F. A., & Lutz, B. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00104.x · Cited by 222
Colorado Family Physicians' Attitudes Toward Medical Marijuana
Kondrad, E., & Reid, A. (2013) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2013.01.120089 · Cited by 221
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Iskedjian, M., Bereza, B., Gordon, A., Piwko, C., & Einarson, T. R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x158066 · Cited by 216
Cannabis use and mania symptoms: A systematic review and meta-analysis
Gibbs, M., Winsper, C., Marwaha, S., Gilbert, E., Broome, M., & Singh, S. P. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.016 · Cited by 214
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal
Scavone, J. L., Sterling, R. C., & Van Bockstaele, E. J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.034 · Cited by 209
Constituents of Cannabis Sativa
Rock, E. M., & Parker, L. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_1 · Cited by 208
Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice
Moreira, F. A., & Guimarães, F. S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.040 · Cited by 206
Storr, M., Devlin, S., Kaplan, G. G., Panaccione, R., & Andrews, C. N. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000440982.79036.d6 · Cited by 206
The Pharmacological Case for Cannabigerol
Nachnani, R., Raup-Konsavage, W. M., & Vrana, K. E. (2021) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000340 · Cited by 203
Self-citationEffect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study
Tomida, I., Azuara-Blanco, A., House, H., Flint, M., Pertwee, R. G., & Robson, P. J. (2006) · Journal of Glaucoma · doi:10.1097/01.ijg.0000212260.04488.60 · Cited by 201
Cannabinoids as therapeutic agents in cancer: current status and future implications
Chakravarti, B., Ravi, J., & Ganju, R. K. (2014) · Oncotarget · doi:10.18632/oncotarget.2233 · Cited by 200
Lynch, M. E., & Ware, M. A. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9600-6 · Cited by 195
Hazekamp, A. (2018) · Medical Cannabis and Cannabinoids · doi:10.1159/000489287 · Cited by 188
Kaczocha, M., Vivieca, S., Sun, J., Glaser, S. T., & Deutsch, D. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304907 · Cited by 187
Moltke, J., & Hindocha, C. (2021) · Journal of Cannabis Research · doi:10.1186/s42238-021-00061-5 · Cited by 178
Beyond THC and Endocannabinoids
Pacher, P., Kogan, N. M., & Mechoulam, R. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021441 · Cited by 175
Navari, R. M. (2013) · Drugs · doi:10.1007/s40265-013-0019-1 · Cited by 174
Metabolism of the Endocannabinoid Anandamide: Open Questions after 25 Years
Maccarrone, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00166 · Cited by 172
Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
Szaflarski, J. P., & Bebin, E. M. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.135 · Cited by 168
Palmitoylethanolamide in CNS health and disease
Raso, G. M., Russo, R., Calignano, A., & Meli, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.006 · Cited by 165
PETROCELLIS, L. D., Starowicz, K., Moriello, A. S., Vivese, M., Orlando, P., & Marzo, V. D. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.008 · Cited by 161
Manrique-Garcia, E., Zammit, S., Dalman, C., Hemmingsson, T., Andréasson, S., & Allebeck, P. (2011) · Psychological Medicine · doi:10.1017/s0033291711002078 · Cited by 160
Fitzcharles, M., Baerwald, C., Ablin, J. N., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0084-3 · Cited by 159
A pilot study using nabilone for symptomatic treatment in Huntington's disease
Curtis, A., Mitchell, I., Patel, S., Ives, N., & Rickards, H. (2009) · Movement Disorders · doi:10.1002/mds.22809 · Cited by 158
Endocannabinoid System Components: Overview and Tissue Distribution
Joshi, N., & Onaivi, E. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21737-2_1 · Cited by 155
Porcella, A., Maxia, C., Gessa, G. L., & Pani, L. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01401.x · Cited by 154
Human Laboratory Studies on Cannabinoids and Psychosis
Sherif, M. A., Radhakrishnan, R., D’Souza, D. C., & Ranganathan, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.01.011 · Cited by 150
Therapeutic potential of cannabis-related drugs
Alexander, S. P. H. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.07.001 · Cited by 149
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
Gomes, F. V., Llorente, R., Del Bel, E. A., Viveros, M.-P., López-Gallardo, M., & Guimarães, F. S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.015 · Cited by 147
Kramer, J. L. (2014) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21260 · Cited by 146
Method for the Analysis of Cannabinoids and Terpenes in Cannabis
Giese, M. W., Lewis, M. A., Giese, L., et al. (2015) · Journal of AOAC International · doi:10.5740/jaoacint.15-116 · Cited by 144
Impact of Cannabis Use on the Development of Psychotic Disorders
Wilkinson, S. T., Radhakrishnan, R., & D’Souza, D. C. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0018-7 · Cited by 141
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
van Egmond, N., Straub, V. M., & van der Stelt, M. (2020) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 139
Effects of Cannabinoids on Sleep and their Therapeutic Potential for Sleep Disorders
Kaul, M., Zee, P. C., & Sahni, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01013-w · Cited by 126
Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats
Murillo‐Rodríguez, E., Millán‐Aldaco, D., Palomero‐Rivero, M., Mechoulam, R., & Drucker-Colín, R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.102 · Cited by 125
Influence of cannabidiol on delta‐9‐tetrahydrocannabinol effects
Dalton, W. S., Martz, R. C., Lemberger, L., Rodda, B. E., & Forney, R. B. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976193300 · Cited by 123
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
Turna, J., Patterson, B. A., & Ameringen, M. V. (2017) · Depression and Anxiety · doi:10.1002/da.22664 · Cited by 117
Weber, M., Goldman, B., & Truniger, S. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.200642 · Cited by 116
Effects of increasing cannabis potency on adolescent health
Wilson, J., Freeman, T. P., & Mackie, C. J. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30342-0 · Cited by 113
Effect of Dronabinol on Central Neuropathic Pain After Spinal Cord Injury
Rintala, D. H., Fiess, R. N., Tan, G., Holmes, S. A., & Bruel, B. M. (2010) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181f1c4ec · Cited by 108
The endocannabinoid system as a target for addiction treatment: Trials and tribulations
Sloan, M. E., Gowin, J. L., Ramchandani, V. A., Hurd, Y. L., & Foll, B. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.031 · Cited by 104
Cudaback, E., Marrs, W., Moeller, T., & Stella, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008702 · Cited by 96
Endocannabinoids in brain plasticity: Cortical maturation, HPA axis function and behavior
Dow-Edwards, D. L., & Silva, L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.08.037 · Cited by 93
Amyotrophic Lateral Sclerosis: Review
Salameh, J. S., Brown, R. H., & Berry, J. D. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1558984 · Cited by 91
Botsford, S. L., Yang, S., & George, T. P. (2020) · The American Journal on Addictions · doi:10.1111/ajad.12963 · Cited by 88
Gustafsson, S. B., Lindgren, T., Jönsson, M. E., & Jacobsson, S. O. P. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0788-5 · Cited by 85
Hypnoticlike effects of cannabidiol in the rat
Monti, J. M. (1977) · Psychopharmacology · doi:10.1007/bf00497858 · Cited by 84
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses
Rajabally, Y. A., Adams, D., Latour, P., & Attarian, S. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310835 · Cited by 83
Schlag, A. K., O'Sullivan, S. E., Zafar, R. R., & Nutt, D. J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108586 · Cited by 82
Côté, M., Trudel, M., Wang, C., & Fortin, A. (2015) · Annals of Otology Rhinology & Laryngology · doi:10.1177/0003489415612801 · Cited by 80
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder
Betthauser, K. D., Pilz, J., & Vollmer, L. E. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140523 · Cited by 78
Rocha, F. C. M., Santos-Junior, J. G., Stefano, S. C., & da Silveira, D. X. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1277-1 · Cited by 76
Crane, N. A., Schuster, R. M., & González, R. (2013) · Journal of the International Neuropsychological Society · doi:10.1017/s135561771300088x · Cited by 74
Different Effects of Cannabis Abuse on Adolescent and Adult Brain
Dhein, S. (2020) · Pharmacology · doi:10.1159/000509377 · Cited by 71
Cannabinoids for treatment of glaucoma
Novack, G. D. (2016) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000242 · Cited by 69
Pooyania, S., Ethans, K., Szturm, T., Casey, A., & Perry, D. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2009.12.025 · Cited by 64
Milosev, L. M., Psathakis, N., Szejko, N., Jakubovski, E., & Müller‐Vahl, K. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0050 · Cited by 59
Crane, N. A., Schuster, R. M., Mermelstein, R. J., & González, R. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1020770 · Cited by 51
Ogawa, S., & Kunugi, H. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150612225212 · Cited by 51
Prospects for the Use of Cannabinoids in Psychiatric Disorders
Graczyk, M., Łukowicz, M., & Dzierżanowski, T. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.620073 · Cited by 51
Kleine‐Brueggeney, M., Greif, R., Brenneisen, R., Urwyler, N., Stueber, F., & Theiler, L. G. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000877 · Cited by 49
Ganesh, S., Cortes-Briones, J., Ranganathan, M., Radhakrishnan, R., Skosnik, P. D., & D’Souza, D. C. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa031 · Cited by 49
Thanabalasingam, S. J., Ranjith, B., Jackson, R., & Wijeratne, D. T. (2021) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864211018561 · Cited by 48
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Pryce, G., & Baker, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_7 · Cited by 47
Synthetic Cannabinoid Activity Against Colorectal Cancer Cells
Raup‐Konsavage, W. M., Johnson, M., Legare, C. A., Yochum, G. S., Morgan, D. J., & Vrana, K. E. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0065 · Cited by 45
Self-citationBajaj, S., Jain, S., Vyas, P., Bawa, S., & Vohora, D. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.022 · Cited by 44
Bidwell, L. C., Metrik, J., McGeary, J. E., Palmer, R. H. C., Francazio, S. K., & Knopik, V. S. (2013) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2013.74.867 · Cited by 43
Blumentrath, C. G., Dohrmann, B., & Ewald, N. (2017) · PubMed Central · doi:10.3205/000247 · Cited by 43
Cannabis in the Treatment of Dystonia, Dyskinesias, and Tics
Koppel, B. S. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0376-4 · Cited by 41
Franklin, J. M., & Carrasco, G. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.454843 · Cited by 34
Korzh, A., Keren, O., Gafni, M., Bar-Josef, H., & Sarne, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2007.10.070 · Cited by 33
Endocannabinoid signaling pathways: beyond CB1R and CB2R
Biringer, R. G. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00622-6 · Cited by 33
Erdozain, A. M., Díez-Alarcia, R., Meana, J. J., & Callado, L. F. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.10.018 · Cited by 31
Urbi, B., Owusu, M. A., Hughes, I. P., Katz, M., Broadley, S., & Sabet, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14639 · Cited by 30
Quality of Life in Patients with Pancreatic Cancer
Lee, V., Cheng, H., Li, G., & Saif, M. W. (2012) · PubMed · doi:10.6092/1590-8577/2679 · Cited by 28
Cannabidiol (CBD) and cognition in epilepsy
Gaston, T. E., Martin, R. C., & Szaflarski, J. P. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108316 · Cited by 23
Endocannabinoid Mechanisms Influencing Nausea
Sticht, M. A., Rock, E. M., Limebeer, C. L., & Parker, L. A. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.09.001 · Cited by 21
Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
Wilkerson, J. L., Bilbrey, J. A., Felix, J. S., Makriyannis, A., & McMahon, L. R. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173192 · Cited by 21
Psychiatric Symptoms, Salivary Cortisol and Cytokine Levels in Young Marijuana Users
Cloak, C. C., Alicata, D., Ernst, T. M., & Chang, L. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9606-0 · Cited by 20
Cannabis Hyperemesis Syndrome in Palliative Care: A Case Study and Narrative Review
Howard, I. M. (2019) · Journal of Palliative Medicine · doi:10.1089/jpm.2018.0531 · Cited by 17
Crowley, K., de Vries, S. T., & Moreno‐Sanz, G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00564 · Cited by 16
Lou, K. K. W., Murphy, S., & Talbot, C. (2021) · Palliative Medicine · doi:10.1177/02692163211045314 · Cited by 12
Cited by
Mental health misinformation on social media: Review and future directions
Starvaggi, I., Dierckman, C., & Lorenzo-Luaces, L. (2024) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2023.101738 · Cited by 88
Metadata
- Authors
- Legare, C. A., Raup-Konsavage, W. M., & Vrana, K. E.
- Venue
- Pharmacology
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 107
- Issue
- 3-4
- Pages
- 131-149
- ISSN
- 0031-7012 (ISSN-L)
- 1423-0313
- OpenAlex
- W4210771126
- Cited by
- 275
- References
- 137
- FWCI
- 29.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.